BioLife Solutions (BLFS) Tops Q4 EPS by 2c

BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.82 million versus the consensus estimate of $1.85 million.

2016 Expectations

Management has the following expectations for 2016:

• Revenue growth: We expect total revenue to exceed $10 million in 2016, with 20% to 30% growth in biopreservation media revenue over 2015 and including revenue from our biologistex cold chain logistics SaaS.
• Gross Margin: We expect gross margin to be in the range of 55% to 65% for the year.
• Operating Expenses: We anticipate a modest increase in operating expenses in 2016 as we continue to invest in sales and marketing efforts and to develop, test, and deploy new releases of our biologistex cold chain logistics app.
• Cash: We ended 2015 with $3.8 million in cash and anticipate that we will continue to use cash in 2016 and achieve cash flow breakeven by the end of 2016.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• ResMed (RMD) Tops Q3 EPS by 20c
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance